Skip to content
10-K

Annual Report

GINKGO BIOWORKS HOLDINGS, INC. DNA DNABW

0001628280-26-012346

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 55.46M sh
Shares Diluted FY 2025 · Dec 31, 2024 51.89M sh
Shares Diluted restated FY 2025 · Dec 31, 2023 48.61M sh
Shares Outstanding FY 2025 · Dec 31, 2025 58.21M sh
Shares Outstanding FY 2025 · Dec 31, 2024 54.37M sh
Capex FY 2025 · Dec 31, 2025 $7.67M
Capex FY 2025 · Dec 31, 2024 $62.54M
Capex FY 2025 · Dec 31, 2023 $40.8M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$171.06M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$319.59M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$295.5M
Cash And Equivalents FY 2025 · Dec 31, 2025 $167.2M
Cash And Equivalents FY 2025 · Dec 31, 2024 $561.57M
Cash And Equivalents FY 2025 · Dec 31, 2023 $944.07M
Cash And Equivalents FY 2025 · Dec 31, 2022 $1.32B
Stockholders Equity FY 2025 · Dec 31, 2025 $508.59M
Stockholders Equity FY 2025 · Dec 31, 2024 $716.06M
Stockholders Equity FY 2025 · Dec 31, 2023 $1.1B
Stockholders Equity FY 2025 · Dec 31, 2022 $1.74B
Current Liabilities FY 2025 · Dec 31, 2025 $95.97M
Current Liabilities FY 2025 · Dec 31, 2024 $107.27M
Total Liabilities FY 2025 · Dec 31, 2025 $611.11M
Total Liabilities FY 2025 · Dec 31, 2024 $661.39M
Current Assets FY 2025 · Dec 31, 2025 $471.84M
Current Assets FY 2025 · Dec 31, 2024 $602.74M
Total Assets FY 2025 · Dec 31, 2025 $1.12B
Total Assets FY 2025 · Dec 31, 2024 $1.38B
Eps Diluted FY 2025 · Dec 31, 2025 −$5.64
Eps Diluted FY 2025 · Dec 31, 2024 −$10.54
Eps Diluted restated FY 2025 · Dec 31, 2023 −$18.37
Eps Basic FY 2025 · Dec 31, 2025 −$5.64
Eps Basic FY 2025 · Dec 31, 2024 −$10.54
Eps Basic restated FY 2025 · Dec 31, 2023 −$18.37
Sga Expense FY 2025 · Dec 31, 2025 $183.29M
Sga Expense FY 2025 · Dec 31, 2024 $246.16M
Sga Expense FY 2025 · Dec 31, 2023 $385.03M
Rd Expense FY 2025 · Dec 31, 2025 $243.77M
Rd Expense FY 2025 · Dec 31, 2024 $424.06M
Rd Expense FY 2025 · Dec 31, 2023 $580.62M
Net Income FY 2025 · Dec 31, 2025 −$312.76M
Net Income FY 2025 · Dec 31, 2024 −$547.03M
Net Income FY 2025 · Dec 31, 2023 −$892.87M
Operating Income FY 2025 · Dec 31, 2025 −$315.28M
Operating Income FY 2025 · Dec 31, 2024 −$559.76M
Operating Income FY 2025 · Dec 31, 2023 −$864.41M
Revenue FY 2025 · Dec 31, 2025 $170.16M
Revenue FY 2025 · Dec 31, 2024 $227.04M
Revenue FY 2025 · Dec 31, 2023 $251.46M